L Crocetti
Overview
Explore the profile of L Crocetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
149
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Crocetti L, Quinn M, Schepetkin I, Giovannoni M
Expert Opin Ther Pat
. 2019 Jun;
29(7):555-578.
PMID: 31204543
Introduction: Human neutrophil elastase (HNE) is involved in a variety of serious chronic diseases, especially cardiopulmonary pathologies. For this reason, the regulation of HNE activity represents a promising therapeutic approach,...
2.
Crocetti L, Iezzi R, Goldberg S, Bilbao J, Sami A, Akhan O, et al.
Eur Rev Med Pharmacol Sci
. 2018 Jun;
22(12):3896-3904.
PMID: 29949165
Percutaneous liver ablation has become a cornerstone of the recently developed subspecialty of radiology - that is, interventional oncology. Thermal ablation technology has evolved rapidly during the past decades, with...
3.
Malagari K, Iezzi R, Goldberg S, Bilbao J, Sami A, Akhan O, et al.
Eur Rev Med Pharmacol Sci
. 2018 Feb;
22(2):372-381.
PMID: 29424893
Transarterial therapies in the setting of primary and secondary liver malignancies are becoming an essential part of the oncology landscape. The mechanism of action of c-TACE is the induction of...
4.
Bilbao J, Iezzi R, Goldberg S, Sami A, Akhan O, Giuliante F, et al.
Eur Rev Med Pharmacol Sci
. 2017 Oct;
21(18):4014-4021.
PMID: 29028102
Microsphere and particle technology represent the next-generation agents that have formed the basis of interventional oncology, an evolving subspecialty of interventional radiology. One of these platforms, yttrium-90 microspheres, is increasingly...
5.
Crocetti L, Bargellini I, Cioni R
Clin Radiol
. 2017 Mar;
72(8):626-635.
PMID: 28258743
Hepatocellular carcinoma (HCC) represents one of the few cancers for which locoregional treatments are recognised as being able to cure and/or prolong survival and are included in international guidelines. This...
6.
De Simone P, Crocetti L, Pezzati D, Bargellini I, Ghinolfi D, Carrai P, et al.
Transplant Proc
. 2014 Feb;
46(1):241-4.
PMID: 24507059
Background: Recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT) is still associated with a dismal outcome. Combination therapy with everolimus (EVL) and vascular endothelial growth factor inhibitor sorafenib (SORA)...
7.
Bartolozzi C, Crocetti L, Della Pina M
JBR-BTR
. 2008 Apr;
90(6):475-81.
PMID: 18376759
The diagnosis of hepatocellular carcinoma is based on imaging examinations in combination with clinical and laboratory findings. Despite technological advances, imaging cirrhotic patients remains a challenging issue, since preneoplastic hepatocellular...
8.
Cioni D, Lencioni R, Rossi S, Garbagnati F, Donati F, Crocetti L, et al.
AJR Am J Roentgenol
. 2001 Sep;
177(4):783-8.
PMID: 11566673
Objective: We evaluated the accuracy of contrast-enhanced harmonic power Doppler sonography in assessing the outcome of radiofrequency thermal ablation of hepatocellular carcinoma. Subjects And Methods: Fifty patients with 65 hepatocellular...
9.
Bartolozzi C, Crocetti L, Cioni D, Donati F, Lencioni R
Hepatogastroenterology
. 2001 May;
48(38):352-8.
PMID: 11379308
Interventional procedures for percutaneous tumor ablation have gained an increasingly important role in the treatment of liver malignancies. After interventional therapies, diagnostic imaging has the key role in determining if...
10.
Bartolozzi C, Crocetti L, Menchi I, Ortori S, Lencioni R
Abdom Imaging
. 2001 Feb;
26(2):111-22.
PMID: 11178685
No abstract available.